No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Coronary Syndrome / drug therapy
-
Blood Platelets / drug effects
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
Humans
-
Injections, Subcutaneous
-
Organophosphonates / administration & dosage
-
Organophosphonates / pharmacology*
-
Organophosphonates / therapeutic use
-
Platelet Aggregation Inhibitors / administration & dosage
-
Platelet Aggregation Inhibitors / pharmacology*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Purinergic P2Y Receptor Antagonists / administration & dosage
-
Purinergic P2Y Receptor Antagonists / pharmacology*
-
Purinergic P2Y Receptor Antagonists / therapeutic use
-
Pyrimidines / administration & dosage
-
Pyrimidines / pharmacology*
-
Pyrimidines / therapeutic use
Substances
-
Organophosphonates
-
Platelet Aggregation Inhibitors
-
Purinergic P2Y Receptor Antagonists
-
Pyrimidines
-
selatogrel